STAT STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We dissect crucial discoveries.

We take you inside the science labs and hospitals, biotech boardrooms and political backrooms. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all.

News: Trump administration uses rare authority to claw back nearly $1B in spending approved by Congress
09/26/2026

News: Trump administration uses rare authority to claw back nearly $1B in spending approved by Congress

President Trump is canceling nearly $1 billion in spending approved by Congress, and most of the cuts are focused on HHS programs that serve refugees and unaccompanied minors.

https://trib.al/6N1Mojz
09/25/2026

https://trib.al/6N1Mojz

The Justice Department said in June that it would no longer enforce laws that prioritized people with disabilities living and receiving services in their communities, rather than in nursing homes or facilities. It is making good on that promise.

“With this latest appointment, mifepristone has a new boss but an old problem,” writes Julie F. Kay, founder and CEO of ...
09/25/2026

“With this latest appointment, mifepristone has a new boss but an old problem,” writes Julie F. Kay, founder and CEO of Reproductive Futures.

“With this latest appointment, mifepristone has a new boss but an old problem,” writes Julie F. Kay, founder and CEO of Reproductive Futures.

“The epidemiology and genetics of heart attack and stroke risk, for now, seem to have outpaced what more we can actually...
09/25/2026

“The epidemiology and genetics of heart attack and stroke risk, for now, seem to have outpaced what more we can actually do about it."

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical ind...
09/25/2026

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

With an eye toward pandemic preparedness, a U.N.-backed agency has signed sub-licensing deals with 11 manufacturers to d...
09/25/2026

With an eye toward pandemic preparedness, a U.N.-backed agency has signed sub-licensing deals with 11 manufacturers to develop and manufacture generic versions of a Roche influenza treatment.

With an eye toward pandemic preparedness, a U.N.-backed agency has signed sub-licensing deals related to generic versions of a Roche influenza treatment.

https://trib.al/pUR3YGU
09/25/2026

https://trib.al/pUR3YGU

The FDA approved Eli Lilly’s Onswik, a once-weekly basal insulin for adults with type 2 diabetes, offering patients an alternative to daily long-acting insulin injections.

With an eye toward pandemic preparedness, a U.N.-backed agency has signed sub-licensing deals related to generic version...
09/25/2026

With an eye toward pandemic preparedness, a U.N.-backed agency has signed sub-licensing deals related to generic versions of a Roche influenza treatment.

With an eye toward pandemic preparedness, a U.N.-backed agency has signed sub-licensing deals related to generic versions of a Roche influenza treatment.

“A discrepancy between how federal and state public health officials determine measles deaths will only increase public ...
09/25/2026

“A discrepancy between how federal and state public health officials determine measles deaths will only increase public confusion,” write Denys T. Lau and Jennifer D. Schoendorf.

“A discrepancy between how federal and state public health officials determine measles deaths will only increase public confusion,” write Denys T. Lau and Jennifer D. Schoendorf.

At least five candidates are in the running to become the next director-general of the World Health Organization, a job ...
09/25/2026

At least five candidates are in the running to become the next director-general of the World Health Organization, a job that will come with extraordinary challenges.

At least five candidates are in the running to become the next director-general of the WHO, a job that will come with extraordinary challenges.

Address

1 Exchange Place
Boston, MA
02120

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm

Alerts

Be the first to know and let us send you an email when STAT posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share